MedTrace Logo

Efficacy of Near Infrared Phototherapy in Type 2 Diabetic Neuropathy

NCT02798393 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2017-03-01

No results posted yet for this study

Summary

This is a double blind, randomized, placebo-controlled study in which a total of 120 patients will be selected from a broad spectrum group of typical Americans (all demographics including various races and both genders as well as ages from 25-90) who have confirmed Type 2 Diabetes Mellitus and suffer from mild to moderate lower extremity Peripheral Neuropathy. All patients will meet inclusion and/or exclusion criteria.

Conditions

Interventions

OTHER

Infrared Phototherapy

Subjects will wear a cuff on their extremities for a set period of time at set intervals over a period of several weeks. The cuff will emit the Infrared Phototherapy treatment (or sham if randomized to the non-treat group).

OTHER

Sham

Sponsors & Collaborators

  • Clin-Assist, LLC

    collaborator UNKNOWN

  • Midwest Medical Research

    collaborator UNKNOWN

  • Healthlight, LLC

    lead INDUSTRY

Principal Investigators

  • Kipp Van Camp, DO · Midwest Medical Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02798393 on ClinicalTrials.gov